Clinical Trial Update: Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)

View source ↗

Summary

Clinical trial update on the etiology and immunological pathogenesis of acute exacerbation in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Interstitial Lung Diseases | Status: UNKNOWN